Literature DB >> 10463911

The end of the heparin pump? Dosage regimens for low molecular weight heparins differ.

M Lloyd.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10463911      PMCID: PMC1116449          DOI: 10.1136/bmj.319.7209.575a

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


× No keyword cloud information.
  7 in total

1.  A comparison of low-molecular-weight heparin with unfractionated heparin for unstable coronary artery disease. Efficacy and Safety of Subcutaneous Enoxaparin in Non-Q-Wave Coronary Events Study Group.

Authors:  M Cohen; C Demers; E P Gurfinkel; A G Turpie; G J Fromell; S Goodman; A Langer; R M Califf; K A Fox; J Premmereur; F Bigonzi
Journal:  N Engl J Med       Date:  1997-08-14       Impact factor: 91.245

2.  The end of the heparin pump? Low molecular weight heparin has many advantages over unfractionated heparin.

Authors:  N R Grubb; P Bloomfield; C A Ludlam
Journal:  BMJ       Date:  1998-12-05

3.  Spinal and epidural hematoma and low-molecular-weight heparin.

Authors:  D K Wysowski; L Talarico; J Bacsanyi; P Botstein
Journal:  N Engl J Med       Date:  1998-06-11       Impact factor: 91.245

4.  What are the benefits of editorials and non-systematic reviews?

Authors: 
Journal:  BMJ       Date:  1999-01-09

Review 5.  Prevention of postoperative venous thromboembolism.

Authors:  A Bullingham; L Strunin
Journal:  Br J Anaesth       Date:  1995-11       Impact factor: 9.166

Review 6.  Anticoagulants and spinal-epidural anesthesia.

Authors:  E P Vandermeulen; H Van Aken; J Vermylen
Journal:  Anesth Analg       Date:  1994-12       Impact factor: 5.108

7.  Comparison of low-molecular-weight heparin with unfractionated heparin acutely and with placebo for 6 weeks in the management of unstable coronary artery disease. Fragmin in unstable coronary artery disease study (FRIC)

Authors:  W Klein; A Buchwald; S E Hillis; S Monrad; G Sanz; A G Turpie; J van der Meer; E Olaisson; S Undeland; K Ludwig
Journal:  Circulation       Date:  1997-07-01       Impact factor: 29.690

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.